HIV/AIDS Treatment Trends and Progress: Where Do We Stand Today?
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Address: 378 Roan Crescent, Corporate Part North, Randjespark,South Africa
Tel: +27115429500
Web: http://www.lithahealthcare.co.za/company-structure/pharmaceuticals/litha-pharma/pharmafrica.html
Pharmafrica (Pty) Ltd has been in business since 1995. It became a full member of the Litha Group in 2010 but has been in a partnership with Litha since 2006.
The company markets ethical and complimentary healthcare products to niche markets through a wholesaler and direct distribution network. Pharmafrica has a solid reputation and strong relationships within the hospital and specialist environment and are an approved GMP manufacturer.
Pharmafrica is also a member of SMASA (Self Medication Manufacturers Association of South Africa)
Key markets:
Hospitals – Private and Public
Selected Medical Specialists and GP’s
Clinics – Private and Public
Academic Institutions
Retail Pharmacy
Pharmafrica has representatives in all the major areas of South Africa and primarily target the following specialities:
Cardiology
Dermatology
Plastic Surgery
Ophthalmology
Urology
General Medical Practice
Ethical medicines:
Analgesics
Anti-psychotics
Anti-depressants
Viscoelastic in eye surgery
Ophthalmic products
Anti-glaucoma therapy
Urinary incontinence
Topical anti-inflammatories
Complementary medicines:
Nutritive supplements
Vitamin supplements
Scar Management and stretch marks
Ageing and sun damaged skin preparations
Pharmafrica head office is located in Johannesburg and distributes from their warehouse nationally. They have a regional office in Cape Town and a total of 14 sales representatives. The company has regulatory, financial,/admin, marketing, distribution and sales resources and a total of 32 employees.
Pharmafrica represents the following companies:
Goldshield Pharmaceuticals – United Kingdom
Thornton & Ross LTD. – United Kingdom
Bio-technology General (B.T.G) – Israel
Apogepha Arzneimittel GMBH – Germany
Sankyo Pharma – Germany
Ursapharm – Germany
Products:
Cerumol – Ear Drops for ear care
Biolon Prime – Eye care
Biolone – Eye care
Ecotrin – Therapy for Cardiovascular Disease
Stelazine – Treatment of acute and chronic psychoses
Detrunorm – Therapy for an overactive bladder
Elmetacin – Topical NSAIDS
Dyazide – Treatment of fluid retention (edema) and high blood pressure (hypertension).
Diamox- Treatment for Glaucoma
Parnate – Antidepressant
Kamillosan – Baby care ointment
Oculet – Eye care
DS-24 – Nutritional supplement
Trimega – Omega Nutritional supplement
Dermastine Range – Skin and Scar Care
Flexeze Capsules and Gel – Therapy for Arthritis
Tremendous strides have been made in both treatment and prevention of AIDS and it is no longer among the 10 leading causes of death globally, however an estimated 39 million…
Dr Benji Pretorius, the founder of Erada Technology Alliance and a malaria survivor himself, shares his insights into why the development of a truly effective malaria vaccine will only succeed…
Writing in the July 2023 edition of DIA’s Global Forum magazine, Nevena Miletic of Roche and the IFPMA’s Africa Regulatory Network and Ian Hudson from the Bill and Melinda Gates…
The third and final piece in Lenias Hwenda of Medicines for Africa’s series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential…
The second in a three-part series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come (read part one…
In the first of a series looking back at the challenges and successes of HIV/AIDS treatments over the past 40 years and potential medical breakthroughs to come, Lenias Hwenda of…
During the COVID-19 pandemic discussions around increasing access to medicines for low and middle-income countries (LMICs) were often centred on compulsory licensing. As a result, pharma companies were up in…
As part of a special focus on drug development and clinical research in Africa in February 2023’s DIA Global Forum magazine, Lisa Ursella Collins of Innomas Clinical Research, Leslie Sam…
Roughly half of Africa’s 1.1 billion people lack regular access to even the most essential medicines and most of Sub-Saharan Africa depends on imports which make up as much as…
Speaking exclusively to PharmaBoardroom, Medicines for Africa’s Lenias Hwenda gives a comprehensive overview of the African Medicines Agency, why such a regulatory body was needed, how it differs from the…
Lenias Hwenda of Medicines for Africa examines the true impact of access to medicine initiatives in Africa, noting that many of the measures takes are often cosmetic and leave a…
Some of the top pharma news coming out of South Africa including Afrigen’s partnership with US National Institutes of Health (NIH), BioNTech’s efforts to bring an mRNA start-to-finish vaccine manufacturing network…
See our Cookie Privacy Policy Here
